AzTrials
AzTrials

RehabilitationNCT04408196

QoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 Quarantine

An observational study of Rehabilitation, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Coronavirus disease (COVID-19) is caused by the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus. This virus was identified in December 2019 in the Chinese city of Wuhan, in the province of Hubei, where it determined a state of health emergency proclaimed by China on January 30, 2020. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Rehabilitation
How many people
121 participants
Where
1 siteItaly
Study dates
26 May 2020to 22 Feb 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients admitted to inpatients rehabilitation centers Caregivers of patients admitted to inpatients rehabilitation centers

Who may be able to join

  • patients admitted to the centers of the Don Gnocchi Foundation participating in the study and their caregivers will be recruited

Who cannot join

  • For patients: a score on the Mini-Mental State Examination (MMSE) scale lower than 24 which prevents the administration of SF36;
  • For patients and caregivers: failure to acquire informed consent

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Don Gnocchi Foundation

    Rome, 00168

Other trials in Italy

About this study

Official title: Effects of Social Distancing on the Quality of Life and on the Emotional-affective Sphere of Caregivers and Patients Hospitalized in Residential Rehabilitation Departments: an Observational Study.

Coronavirus disease (COVID-19) is caused by the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus. This virus was identified in December 2019 in the Chinese city of Wuhan, in the province of Hubei, where it determined a state of health emergency proclaimed by China on January 30, 2020.

Since February 2020, Italy has been involved in the emergency of the COVID-19 infection, with devastating consequences for the health of the population and the economy of our country. As published by the Italian National Institute of Health, the starting date of the symptoms dates back to the end of January, the first case diagnosed dates back to 21 February 2020 while the first cases of home isolation date back to March 1st, 2020. On March 30, 2020, there were 101739 positive subjects and 11591 deaths (Civil Protection data).

Read more

According to data published by the World Health Organization, most people with COVID-19 develop a flu-like form, 14% develop a severe form that requires hospitalization and oxygen therapy and 5% require an ICU admission.

The emergency from Covid19 made it necessary to provide institutional social distancing conditions which resulted in rehabilitation departments being prohibited from visiting patients by family members and/or caregivers. This event, although necessary, led to the first moment of discomfort on the part of patients and family members; to overcome this reaction "technological" solutions were found, trying to give continuity to the contact between the patient and the family member through the use of video calls. Despite this, the COVID-19 emergency and the limitations resulting from social distancing likely have an impact on both patients and family members/caregivers that needs to be assessed.

Read the detailed description

Aims:

The study aims to measure the quality of life (QoL) and the emotional-affective sphere of patients, currently hospitalized in residential structures, and their family members.

The study data will allow identifying (a) whether the social distancing between family members/caregivers and patients undergoing rehabilitation for orthopedic or neurological disabilities affects the quality of life and the emotional-affective sphere and (b) if these conditions change over time. The data obtained will, therefore, allow identifying those subjects who present a particular fragility of the emotional-affective sphere and who therefore need attention and possibly psychological support that will be prescribed.

Procedures:

Demographic (for patients and caregivers) and anamnestic (only for patients) data will be collected; moreover, disability will be assessed in patients using the modified Barthel index.

Three questionnaires will be administered to patients and caregivers:

  • The Short Form (36) Health Survey (SF36), to evaluate the QoL;
  • The Beck Anxiety Inventory (BAI), to evaluate the emotional state;
  • The Beck Depression Inventory-II (BDI-II), to evaluate mood.

These questionnaires will be administered after one month of hospitalization (T0), and after one (T1) and two (T2) months after T0. Finally, at time T1 and T2 it will be registered if the patient is still hospitalized or discharged (and in the latter case the days between the discharge and the compilation of the questionnaire will be recorded). Since the three selected questionnaires provide for self-administration, to simplify the collection of data relating to caregivers, the implementation and use of an online questionnaire will be assessed. This questionnaire will also provide for the collection of consent to the use of data by the subject and will guarantee their privacy.

Conditions
Rehabilitation
Keywords
rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04408196
Study groupRoleWhat they receive
Patients100 patients admitted to an inpatient rehabilitation facility
Caregivers100 caregivers of patients admitted to an inpatient rehabilitation facility

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Short Form-36 Health Survey (SF36)

    It is a questionnaire to evaluate the Quality of Life

    Measured: After one month of hospitalisation (baseline, T0)

  2. Short Form (36) Health Survey (SF36)

    It is a questionnaire to evaluate the Quality of Life

    Measured: One month after baseline (T1)

  3. Short Form (36) Health Survey (SF36)

    It is a questionnaire to evaluate the Quality of Life

    Measured: Two months after baseline (T2)

  4. Beck Anxiety Inventory (BAI)

    It is a brief, criteria-referenced assessment for measuring anxiety severity and level

    Measured: After one month of hospitalisation (baseline,T0)

  5. Beck Anxiety Inventory (BAI)

    It is a brief, criteria-referenced assessment for measuring anxiety severity and level

    Measured: One month after baseline (T1)

  6. Beck Anxiety Inventory (BAI)

    It is a brief, criteria-referenced assessment for measuring anxiety severity and level

    Measured: Two months after baseline (T2)

  7. Beck Depression Inventory-II (BDI-II)

    It is a brief, criteria-referenced assessment for measuring depression severity

    Measured: After one month of hospitalisation (baseline)

  8. Beck Depression Inventory-II (BDI-II)

    It is a brief, criteria-referenced assessment for measuring depression severity

    Measured: One month after baseline (T1)

  9. Beck Depression Inventory-II (BDI-II)

    It is a brief, criteria-referenced assessment for measuring depression severity

    Measured: Two months after baseline (T2)

Secondary outcomes (1)
  1. modified Barthel Index (mBI)

    It is a measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients or patients with other disabling conditions.

    Measured: After one month of hospitalisation (baseline, T0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2020
  2. Study start26 May 2020
  3. Primary completion15 Feb 2021
  4. Study completion22 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
121 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04408196
Sponsor's protocol ID
FDG_socialdistancing_COVID-19
Status last verified
Mar 2022
First submitted
21 May 2020
Last updated
7 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36. doi: 10.1016/s0895-4356(98)00094-8.

    PubMed 9817120
  • Aprile I, Piazzini DB, Bertolini C, Caliandro P, Pazzaglia C, Tonali P, Padua L. Predictive variables on disability and quality of life in stroke outpatients undergoing rehabilitation. Neurol Sci. 2006 Apr;27(1):40-6. doi: 10.1007/s10072-006-0563-5.

    PubMed 16688598

Questions about this trial

What is this clinical trial studying?

An observational study of Rehabilitation, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Short Form-36 Health Survey (SF36) (time frame: After one month of hospitalisation (baseline, T0)). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04408196, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in